Status:
RECRUITING
Improving Social Communication in Individuals With ASD Using AI
Lead Sponsor:
Stanford University
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
11-35 years
Phase:
NA
Brief Summary
The purpose of this study is to identify whether researched and commonly used face-to-face interventions can be effectively implemented through artificial intelligence (AI) using an application on the...
Detailed Description
Social skill intervention has been proven effective to improve interpersonal and communication skills for people with low social awareness or certain neurological conditions such as autism spectrum di...
Eligibility Criteria
Inclusion
- Primary diagnosis of autism spectrum disorder (ASD)
- Age between 11 to 35
- Ability to engage in social conversation using full sentences for a 20 minute period
- Verbal communication difficulties in an individual targeted area (e.g., empathy) as measured on the conversation sample
- Participants with a co-occuring diagnosis of ADHD, depression, or social anxiety will not be excluded since these are very common in this population and are often related to or a bi-product of difficulties with social conversation.
Exclusion
- Non-documented or self-diagnosis of ASD
- At or above 60% correct responding on targeted area of social conversation during conversation probe
- No access to phone or computer for intervention sessions
- Inability to carry on a conversation during the conversation probe
- Apparent intellectual impairment that interferes with the ability to carry on a conversation (e.g., responds only in single words or does not respond to conversation, lack of understanding of questions or content during conversation probe)
- Non English speaking
- Serious medical or psychiatric issues that may interfere with conversation or the ability to complete the program
- Lack of interest in participating.
Key Trial Info
Start Date :
October 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2050
Estimated Enrollment :
540 Patients enrolled
Trial Details
Trial ID
NCT05987774
Start Date
October 15 2023
End Date
June 30 2050
Last Update
May 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305